Trusted Resources: Education
Scientific literature and patient education texts
Gene Replacement Therapy With Onasemnogene Abeparvovec in Children With Spinal Muscular Atrophy Aged 24 Months or Younger and Bodyweight up to 15 Kg: An Observational Cohort Study
source: The Lancet. Child & Adolescent Health
year: 2022
authors: Weiß C,Ziegler A,Becker LL,Johannsen J,Brennenstuhl H,Schreiber G,Flotats-Bastardas M,Stoltenburg C,Hartmann H,Illsinger S,Denecke J,Pechmann A,Müller-Felber W,Vill K,Blaschek A,Smitka M,van der Stam L,Weiss K,Winter B,Goldhahn K,Plecko B,Horber V,Bernert G,Husain RA,Rauscher C,Trollmann R,Garbade SF,Hahn A,von der Hagen M,Kaindl AM
summary/abstract:Given the novelty of gene replacement therapy with onasemnogene abeparvovec in spinal muscular atrophy, efficacy and safety data are limited, especially for children older than 24 months, those weighing more than 8·5 kg, and those who have received nusinersen. We aimed to provide real-world data on motor function and safety after gene replacement therapy in different patient subgroups.
organization: Department of Pediatric Neurology, Charité-Universitätsmedizin Berlin, Berlin, Germany; Center for Chronically Sick Children, Charité-Universitätsmedizin Berlin, Berlin, Germany.DOI: 10.1016/S2352-4642(21)00287-X
read more
Related Content
-
Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular AtrophySpinal muscular atrophy (SMA) is an auto...
-
Assessment of Cerebral Spinal Fluid Biomarkers and microRNA-Mediated Disease Mechanisms in Spinal Muscular Atrophy P...Cerebral spinal fluid (CSF) is a promisi...
-
New Gene Therapy Transforms SMA (Spinal Muscular Atrophy)https://www.youtube.com/watch?v=C5Dl3iMv...
-
Baby Among the First to Receive Gene Therapy for Spinal Muscular Atrophy After FDA Approvalhttps://www.youtube.com/watch?v=adc6vztu...
-
Lunch & Learn: Gene Therapy for SMAhttps://www.youtube.com/watch?v=YFEMR1ZH...
-
Combination Therapy With Nusinersen and Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy Type ISpinal muscular atrophy (SMA) is a neuro...
-
Expert Recommendations and Clinical Considerations in the Use of Onasemnogene Abeparvovec Gene Therapy for Spinal Mu...Spinal muscular atrophy (SMA) is an auto...